Pressure Ulcer Treatment Products Market By Product Type (Pressure Relief Devices, Wound Dressings, Wound Care Devices, Others), By Wound Type (Stage 1 & 2, Stage 3 & 4, Unstageable And Deep Tissue Injury), By Usage Area (Hospitals, Nursing Homes, Home Care) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Industry Outlook

In the U.S., the prevalence of pressure ulcers in intensive care units ranges from 16.6% to 20.7%. It is also reported that pressure ulcer treatment costs US$ 11 billion per year, with a single wound costing anywhere from $500 to 70,000 dollars. In spite of the availability of better assessment tools, the new CMS ruling eliminating hospital reimbursement when a stage 3 or 4 pressure ulcer is hospital-acquired, and the emergence of new technologies to reduce pressure ulcers, the condition remains a significant healthcare problem. Traditionally, prevention and management of pressure ulcers remained the responsibility of nursing staff. However, today it is viewed more as a healthcare community problem, with everyone from the patient to the nursing staff considered a stakeholder. The implications of pressure ulcers on patients and the healthcare system are vast and vary depending on the severity, tissue damage, patient condition, and effect on lifestyle. Growth in awareness regarding these implications will augment the patient's understanding of the need for the implementation of effective prevention and management strategies.

Market Synopsis

Wound Dressings to Dominate the Global Market

Among the different types of treatment products used for pressure ulcers, dressings are observed to be the largest revenue-generating segment. Dressings are chosen depending on the nature of the wound to be treated. None of the dressings used for treating pressure ulcers have a clear superiority, and the choice of dressing is up to the physicians, depending on the type of wound to be treated. Parameters considered for the choice of dressing are depth, size, amount of exudate, surrounding skin condition, and so on. Yet, advanced dressing products such as hydrocolloids, alginates, and foams occupy a larger market share. Their greater demand in the treatment of advanced three and 4-stage pressure ulcers and the higher prices of these products contribute to the dominance of these product types. Additionally, their greater efficacy in addressing the issue of exudates and better absorbent properties allow for greater demand for advanced wound dressing products in the global market.

During the forecast period, stage 3 and 4 wound types will dominate the global market.

Currently, stage 3 and 4 bedsores account for the majority of the global market for pressure ulcer treatment products. The precise determination of the stage of these wound types and the requirement of a longer duration to heal such wounds mainly contribute to the prominence of this segment. A typical stage 3 wound takes one to four months to heal completely. Stage 4 cases may also take several months for complete healing. Therefore, the consumption of wound healing agents is high in such wound stages where the possibility of moving the patient to hospital settings is significantly high. Moreover, the requirement for advanced wound healing agents such as hydrogels, hydrocolloids, alginates, and antimicrobial agents is also the highest in these wound types. As a result, the higher prices of these products contribute to this segment's dominance in the global market.

Hospitals will continue to be the largest consumers of pressure ulcer treatment products.

Based on the types of usage areas, the global market for pressure ulcer treatment products is categorized into hospitals, nursing homes, and home care. Among these, hospitals comprise the largest segment of these products. Greater patient footfall, higher affordability for advanced products such as powered surfaces and novel mattresses, and better reimbursements are the key factors settling the dominance of the hospital segment. The demand for pressure ulcer treatment products in nursing homes is anticipated to remain stable through the forecast period. Greater uptake of these products in nursing homes will be consistently observed in North America, Western Europe, and Japan. Additionally, though the home care segment currently holds a small market share, increasing preference for moving chronic disease patients from hospitals to home care in order to mitigate cost constraints will render this segment the fastest growth during the forecast period.

Asia Pacific to Rapidly Advance Due to a Perpetually Growing Chronic Patient Pool

North America is the current leader in the global market for pressure ulcer treatment products. There is a significant prevalence of chronic diseases in this region, and obesity is the main factor contributing to its dominance. Greater affordability and the existence of a better reimbursement system also play a critical role in the leading position of the North American market. Asia Pacific is expected to progress at a rapid pace during the forecast period. The Asia-Pacific market is characterized by increased domestic company entry, thriving healthcare infrastructure, and rising disposable incomes to afford advanced treatment solutions. Realizing the untapped opportunities in Asia Pacific, several international players with strongholds in North America and Europe have enhanced their penetration activities in the region. On the other hand, a lack of awareness and lower rates of diagnosis will restrict the growth of some parts of the African market.

Periods of History and Forecast

This research report presents the analysis of each considered segment for the period from 2016 to 2026, using 2017 as the base year for estimations. Compounded annual growth rates (CAGRs) for each segment are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

This report presents a market analysis of pressure ulcer treatment products, offers quantitative information on the market in terms of market size, and forecasts market segmentation for the period from 2016 to 2026. The qualitative information incorporated in the report includes market dynamics such as market drivers, challenges, and opportunities relevant to the industry. For the purpose of this study, the global market for pressure ulcer treatment products is studied for product types, wound types, usage area, and geography.

The report also includes a competitive analysis of the incumbents in the global market for pressure ulcer treatment products. The study also presents a brief profile of such market players in terms of their business overview, product portfolio, financial information, and key developments. Such major market players considered in this report include Smith & Nephew plc, ConvaTec, Inc., Coloplast Group, Acelity L.P., Inc., B. Braun Melsungen AG, Cardinal Health, Mölnlycke Health Care AB, Integra LifeSciences Corporation, 3M Healthcare, Essity Aktiebolag, Hill-Rom Holdings, Inc., BSN Medical, and ArjoHuntleigh.

Key questions are answered in this report.

  • What is the current market size of the pressure ulcer treatment products industry?
  • How are pressure relief devices segmented in the global market?
  • At what CAGR will the global market for pressure ulcer treatment products progress during the forecast period from 2018 to 2026?
  • What are the prevalent drivers and challenges in the global market?
  • Which lucrative opportunities are present in the market for new and existing players?
  • Which strategies are being adopted by major market players to maintain and augment their market positions?
  • How will North America fare on the global front in light of the rapid advances of the Asia-Pacific market?
  • What is the position of emerging markets in the Middle East and Africa, Latin America, and Asia Pacific?

Frequently Asked Questions:

The market for Pressure Ulcer Treatment Products is expected to reach US$ 70,000 in 2026.

The Pressure Ulcer Treatment Products market is expected to see significant CAGR growth over the coming years,at 16.6%.

The report is forecasted from 2018-2026.

The base year of this report is 2017.

Smith & Nephew plc,ConvaTec, Inc.,Coloplast Group,Acelity L.P., Inc., B. Braun Melsungen AG are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Sep 2018
Category:  Medical Devices
Report ID:   59332
Report Format:   PDF
Pages:   120
Rating:    4.1 (56)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support